About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, October 23rd, 2013

The QualityStocks
Daily Stock List


Stevia First Corp. (STVF)

Market Authority, Oakshire News Bulletin, and StreetAuthority Financial reported this week on Stevia First Corp. (STVF), Paragon Report, and Investor Ideas did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Yuba City, California, Stevia First Corp. focuses on the cultivation of stevia, which is an all-natural zero-calorie sweetener. Stevia is a plant from the sunflower family that is native to Paraguay. The leaf of the stevia plant has 9 to 12 sweet-tasting compounds. These are recognized as steviol glycosides, including Stevioside (STV) and Rebaudioside A, the sweetest and best tasting of the compounds. Stevia plant leaves are the source of safe, natural, zero-calorie extracts used as sweeteners.
The Company is working to establish a vertically-integrated business in the U.S. that uses technological expertise in fermentation-based stevia production and improves upon traditional stevia farming and processing methods. Stevia First’s research and development will center on high-value research and development targets (including fermentation-based stevia production methods) that may reduce the need for stevia leaf production. In addition, the Company work’s to breed advanced varieties of the stevia plant. They will work to develop stevia products that optimize sweetness levels, taste, adaptability, as well as ease of production.

Stevia First is fostering support and acceptance for stevia. They are doing this through increasing their involvement within the U.S. Departments of Agriculture’s (USDA's) IR-4 Program and helping provide domestic stevia growers with tools for long-term, reliable stevia leaf production. This past May, the herbicides Envoy (Clethodim), Dual Magnum (S-Metolachlor), and Prowl H20 (Pendimethalin), received commercial and manufacturer support to be elevated to high priority status in the Western Region's IR-4 Program. This prioritization change was facilitated by Stevia First acting together with researchers from the USDA, UC Davis, and North Carolina State University.

Earlier in October, Stevia First announced their entry into a retail distribution and marketing support agreement with GAB Innovations of Vancouver, British Columbia. Stevia First’s objective is to maximize the relationship with GAB to drive the Company's stevia product development and to increase the penetration of mainstream healthy messaging concerning sweetener use. GAB is a North American distributor of premium natural health care products.

Stevia First Corp. (STVF), closed Wednesday's trading session at $0.38, up 1.36%, on 250,961 volume with 83 trades. The average volume for the last 60 days is 101,029 and the stock's 52-week low/high is $0.291/$0.684.

Kabe Exploration, Inc. (KABX)

PennyStocks24, MomentumOTC, StockBomb.com, StockRockandRoll, StockLockandLoad, SmallCapInvestorDaily, PennyStockScholar, OTCtipReporter, MassiveStockProfits, and Wallstreetlivechat reported earlier on Kabe Exploration, Inc. (KABX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Kabe Exploration, Inc. is an oil & gas exploration and development company. They focus on acquiring mineral rights in prolific shale plays for production. The Company’s purpose is to acquire oil and gas assets, oil and gas exploration, refinery and pipeline sectors of the energy industry. Kabe Exploration is based in San Diego, California. The Company lists on the OTCQB.

Kabe has 7,300 acres of oil leases in the highly productive Mississippian field of southern Kansas. The Company’s five year operational plan will bring 24 new oil wells into production. The estimation is that each well in the area will yield 400,000 barrels of oil—a potential 9,600,000 total barrels for the project.

On February 21, 2013, Kabe purchased 320 mineral lease acres in Butler County, Kansas, representing an 81 percent Net Revenue Interest (NRI). The Company plans to drill shallow wells, 3300-6000 ft., on a turnkey basis - a very low cost drilling program. They hope to achieve production of roughly 100-200 barrels per day, or BPD, for each well. The Company’s plan is to drill one well at first and up to 7 wells if results from the first one are positive.

At present, Kabe Exploration is in a pre-production phase. They are gearing up towards full production development. In August 2013, Kabe Exploration announced a 1031 exchange with their joint venture partner International Equity Partners Oil & Gas, Inc. to acquire 10,000,000 shares of their common stock. International Equity Partners Oil & Gas was also in talks with Kabe Exploration’s largest shareholder to acquire a controlling block in a private sale. International Equity Partners Oil & Gas will contribute capital and expertise toward developing the assets for production.

Yesterday, Kabe Exploration issued a letter to shareholders. Their management team announced their plans to file an S1 registration of shares to raise a significant amount of capital to boost the growth of the Company. Kabe’s anticipation is that they will raise approximately $7 Million for operating capital and start to acquire producing assets for immediate revenue growth.

Kabe Exploration, Inc. (KABX), closed Wednesday's trading session at $0.0073, up 21.67%, on 484,816 volume with 19 trades. The average volume for the last 60 days is 554,623 and the stock's 52-week low/high is $0.0044/$0.12.

Jones Soda Co. (JSDA)

Stock Analyzer, SuperNova Elite, Wealthpire Inc., and SmarTrend Newsletters reported earlier on Jones Soda Co. (JSDA), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Jones Soda Co. is a foremost premium beverage company known for their unique flavors. The Company markets and distributes premium beverages under the Jones® Soda, Jones Zilch®, Natural Jones™ Soda, and WhoopAss™ Energy Drink brands. Jones Soda sells by way of their distribution network in markets primarily across North America. Jones Soda sells through traditional beverage retailers. The Company has their corporate headquarters in Seattle, Washington,

Jones Soda is known for their variety of flavors, highest quality ingredients (including pure cane sugar) and innovative labeling technique that incorporates ever-changing photos sent in from their customers. In addition, the Company offers assorted products, such as soda with customized labels, wearables, candy, and other items.

The Company offers Pure Cane Soda in an assortment of flavors. They also offer their Jones Zilch drinks in four flavors – Cola, Vanilla Bean, Black Cherry, and Pomegranate. Their Jones Soda candy includes Cola Candy, Oh Zone Jumble Candy, Pike Place Jumble Candy, 9th Ave Jumble Candy, Energy Booster Candy, Limes & Orange Sour Candy, and Spiked Punch Sour Candy. Jones Gear products include Shorts, Sweatshirts, Tank Tops, Tee-Shirts, Hats, iPhone 5 Cases, Windbreakers, Beanies, Caps, Lip Balm, and a Hot Wheels® Van.

This past August, Jones Soda announced the launch of their Michigan-themed Jones Soda, bottled and sold exclusively in the state of Michigan. The Company said that Michigan helped put Jones Soda on the map in the initial years after Jones Soda was founded, and the Company wanted to show their appreciation.

Jones Soda has partnered with Intrastate Distributors, Inc. to bottle Jones Sodas products in Detroit. The labels on this edition of Jones Soda features more than 40 photos showcasing the state of Michigan submitted by the Company’s fans throughout Michigan and the distinctive logos of the Made In Detroit official clothing brand. The Michigan-themed and bottled Jones Soda comes in eight flavors. These are Green Apple, Berry Lemonade, Fufu Berry, Cream Soda, Root Beer, Blue Bubblegum, Strawberry Lime, and Orange & Cream.

Jones Soda Co. (JSDA), closed Wednesday's trading session at $0.76, down 1.30%, on 52,947 volume with 31 trades. The average volume for the last 60 days is 135,045 and the stock's 52-week low/high is $0.24/$0.91.

New Western Energy Corp. (NWTR)

Penny Stocks VIP, Inside Bulls, and SmallCapInvestorDaily reported recently on New Western Energy Corp. (NWTR), PennyStockScholar, OTCtipReporter, and Pennystocktweeters.com did earlier, and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

New Western Energy Corp. is an independent energy company based in Irvine, California. The Company engages in the acquisition, development, production, and exploration of oil, gas, and minerals - chiefly in North America. New Western Gas Corp. is a wholly owned subsidiary of New Western Energy. Founded in 2008, New Western Energy lists on the OTCQB.

The Company centers on acquiring land leases for properties in the U.S. that have shown favorable characteristics for the discovery of oil, natural gas, and other minerals, and entering into joint ventures to acquire assets in regions in the continental U.S.  New Western Energy has acquired working interests in a number of producing oil wells in the Gulf States. The Company is in negotiations to acquire land leases for additional properties.

Oklahoma projects include Glass; Phillips; Jackson; Acro/Selby; Anna; Kerrigan; Calvin; Jameson; Thomas, and Winchester. Texas projects include Trice and Moran. Kansas projects include B&W Ranch; Fields; Smith; Rinck, and Farwell. Their Pennsylvania project is Wellsboro.

New Western Energy looks to add proven reserves and increase production via the use of advanced technologies. This includes detailed reservoir engineering analysis, drilling development wells utilizing sophisticated techniques, and selectively recompleting existing wells. In addition, the Company concentrates on reducing the operating costs associated with their properties.

This month, their New Western Gas subsidiary announced the start of recompletion on two of their existing Fredonia Gas Wells to open additional pay zones of Pennsylvanian age coal at depths ranging from 600 to 1,400 feet. The Fredonia Prospect is in the central portion of the Cherokee Basin Structural Province that extends over much of southeastern Kansas.

This maturely explored basin is best known for its oil and gas production from shallow Pennsylvanian aged Sandstone reservoirs. Based on the recently prepared Estimate of Reserves prepared by Lee Keeling And Associates, Inc., the Fredonia Gas Prospect contains approximately 1,185,530 MCF of proven remaining recoverable gas reserves.

New Western Energy Corp. (NWTR), closed Wednesday's trading session at $0.21, up 16.67%, on 339,464 volume with 120 trades. The average volume for the last 60 days is 29,814 and the stock's 52-week low/high is $0.115/$1.13.

Nord Resources Corp. (NRDS)

Stock Guru reported previously on Nord Resources Corp. (NRDS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A copper mining company, Nord Resources Corp. is producing copper at their Johnson Camp Mine in the state of Arizona. This is their principal asset, located in Dragoon, Arizona, approximately 65 miles east of Tucson. The Johnson Camp Mine is a copper mine and production facility. Founded in 1971, Nord Resources is based in Tucson. The Company lists on the OTCQB.

The Johnson Camp Mine property consists of 59 patented lode mining claims (889 acres), 92 unpatented lode mining claims (1,494 acres) and 509 acres of fee simple lands totaling 2,892 acres. The on-site copper production facility includes a 4,600 gallon per minute solvent extraction plant and tank farm, a 52,000 lb. /day capacity electrowinning plant with 74 cells, 8 million gallons of solution storage, as well as other related equipment.

Recently, Nord Resources announced that they extended the copper cathode sales agreement with Red Kite Master Fund Ltd. for 100 percent of the production from the Johnson Camp Mine, given the expiry of the replacement copper cathode sales agreement between the parties that was in place from January 1, 2013 through September 30, 2013. The agreement runs through December 31, 2013 with renewable extensions by mutual agreement of both parties.

Nord Resources temporarily suspended mining new ore at the Johnson Camp Mine in July of 2010, as the Company pursued financing to permit them to restructure their debt and provide additional capital for constructing a new leaching pad. Nord continues to leach copper from the material previously placed on the existing three pads on their property, processing it through the Johnson Camp Mine's SX-EW plant.

Nord’s expectation is that full operations will recommence once a new leach pad is constructed pending completion of financing. The Company’s current reactivation plan includes attaining the designed copper production rate of 25 million pounds per year of copper cathode within a year after securing financing.

Nord Resources Corp. (NRDS), closed Wednesday's trading session at $0.029, up 31.82%, on 177,500 volume with 4 trades. The average volume for the last 60 days is 37,510 and the stock's 52-week low/high is $0.007/$0.07.

Medifirst Solutions, Inc. (MFST)

PennyStocks24, PickPenny Stocks, Michael Stone, Growing Stocks Reports, Research Driven Investor, OtcWizard, OTCBB Journal, First Penny Picks, HyperSpeedStocks, OTPicks, PennyStockSpy, and AimHighProfits reported on Medifirst Solutions, Inc. (MFST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Medifirst Solutions, Inc. looks for innovative medical and healthcare products and technologies targeted to medical and healthcare professionals and everyday consumers. Listed on the OTC Markets’ OTCQB, the Company plans to develop and establish a consumer and professional medical base and clientele to be used as a pipeline that will allow for expansion with new products and services. Medifirst Solutions has their headquarters in Manalapan, New Jersey.

Medifirst’s commitment is to provide innovative drug free and pain free treatments, services, and products for people to make better and healthier choices and improve their quality of life. The Company’s areas of interest include Drug Fee Pain Management; Stem Cell Therapy; and Pain Diagnostic Technology. In addition, their areas of interest include Malingering; IT (Information Technology) Solutions, as well as Cosmetic Procedures.

At the end of August, Medifirst Solutions announced they would begin offering their LED Botanical Light Therapy in their new Boca Raton, Florida office situated directly across from Boca Raton Regional Hospital. Medifirst has launched a new Health and Wellness Division, called Medi-First Light Therapy Systems with their new and pioneering LED Botanical Light Therapy Systems. The Boca Raton location will focus on the Light Therapy Systems for cosmetic and anti-aging therapy.

In addition, the Company will be announcing a number of other locations as they are creating an infrastructure based on the Botanical Light Therapy Systems and the very positive results they indicate they are achieving. The LED Botanical Light Therapy Systems has not been evaluated by the Food and Drug Administration (FDA).

Yesterday, Medifirst Solutions announced that they signed an agreement with Groupon to launch their LED Botanical Light Therapy in the Boca Medical Spa, the Company’s new Boca Raton, Florida office. Groupon presents to Medifirst Solutions a very effective means of advertising, promoting, and building a patient and client base for their new anti-aging and detoxification "Time Machine Program."

Medifirst Solutions, Inc. (MFST), closed Wednesday's trading session at $0.26, up 4.00%, on 337,228 volume with 98 trades. The average volume for the last 60 days is 133,669 and the stock's 52-week low/high is $0.025/$1.30.

Applied DNA Sciences, Inc. (APDN)

Greenbackers reported recently on Applied DNA Sciences, Inc. (APDN), PennyStocks24, Pennybuster, FeedBlitz, Stock Analyzer did earlier, and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Applied DNA Sciences, Inc. is a provider of botanical-DNA based anti-counterfeiting technology and product authentication solutions. These solutions can help protect products, brands, and the intellectual property (IP) of companies, governments, and consumers from theft, counterfeiting, fraud and diversion. Applied DNA Sciences is based in Stony Brook, New York. The Company’s shares trade on the OTC Markets’ OTCQB.

SigNature® DNA and smartDNA are the Company’s principal anti-counterfeiting and product authentication solutions. In essence, they cannot be copied; they provide a forensic chain of evidence and can be used to prevent crime.

The foundation of SigNature® DNA is on full, double-stranded plant DNA. Applied DNA Sciences does not use single-stranded, “synthetic” DNA. The mark will not wash off, even in aggressive industrial treatment baths. Moreover, results are not hidden or obscured by false positives. SigNature® DNA markers can be used to strengthen brand protection efforts; mark, track and convict criminals; as well as strengthen supply chain security.   

The Company’s products include Cashield™ degradation ink. Cashield™ degradation dye helps limit the benefit of cash-in-transit crime. Products also include digitalDNA™. This is a new security tool that uses the flexibility of mobile communications, the instant accessibility of secure, cloud-based data, and the absolute certainty of DNA to make item tracking and authentication swift, easy, and definitive.

In addition, products include DNAnet® forensic tagging systems. DNAnet intruder tagging systems help to expand and strengthen any security effort through providing a way of directly linking criminals to crimes. Another product the Company offers is FiberTyping™ textile genotyping. FiberTyping is a DNA test developed in collaboration with Supima (representing U.S. pima cotton growers) to provide a way to verify original ELS cotton content present in cotton products.

Last week, Applied DNA Sciences announced that they signed a ten-year option agreement with one of the top four U.S. defense contractors to purchase SigNature DNA® marking technology. The global aerospace and defense company’s present intention is to apply their unique SigNature DNA mark on FSC 5962 microcircuits in support of US Defense Logistics Agency acquisition requirement (DLAD) 52.211-9074. This company is a high-technology leader; they support military services including the Navy, Army, Air Force, and the Missile Defense Agency, and non-military end users, for example NASA and the Department of Homeland Security.

Applied DNA Sciences, Inc. (APDN), closed Wednesday's trading session at $0.12, down 12.09%, on 6,026,453 volume with 392 trades. The average volume for the last 60 days is 1,615,600 and the stock's 52-week low/high is $0.084/$0.305.

Green Technology Solutions, Inc. (GTSO)

FeedBlitz, Best Microcap Stock, and OTC Stock Pick reported earlier on Green Technology Solutions, Inc. (GTSO), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.

Headquartered in Palo Alto, California, Green Technology Solutions, Inc. is a growth-oriented company exploring rare earth minerals and precious metals production worldwide. At present, the Company is identifying possible early stage companies and technology across a range of green technologies and environmentally friendly practices for the purpose of acquiring rights to them, Joint Venture (JV) partnerships, and developing them into marketable products. The Company’s subsidiary is GTSO Resources. Green Technology Solutions’ shares trade on the OTCQB.

Green Technology Solutions identifies, acquires, and develops green technologies. The Company has identified specific market segments to date. One is the advancement of cleaner global mining technologies, with an emphasis on rare earth and precious metals mining applications. A second is the development of additional markets for environmentally friendly methods of recovering minerals from electronic waste. A third is smart grid technology.

In September, Green Technology Solutions finalized a JV agreement with Chilerecicla to purchase and export e-waste. Chilerecicla is a premier Chile-based e-waste exporter. The agreement with Chilerecicla allows the Company to work toward the development of a global waste management collection, processing, and sales operation.

In addition, they will oversee the development of projects to acquire primarily electronics and plastic waste to sell minerals, metals, and plastics for reuse. With this JV agreement, Chilerecicla will purchase and export e-waste from Latin American suppliers to two of the world’s most prolific smelters in Belgium and Japan.

Last week, Green Technology Solutions announced that their key JV partner Chilerecicla is moving forward with the purchase of raw materials to be exported to Europe as they continue going after a share of the growing urban mining market projected to approach $25 billion over the next five years. Chilerecicla is investing in products sourced through Chile and Bolivia depending on grade. Those materials will then be shipped to Belgian smelting company Umicore. The transaction marks the official launch of Chilerecicla’s Latin American operation.

Green Technology Solutions is exploring additional uses of waste materials in the thriving waste-to-energy marketplace. Late in 2012, the Company acquired Global Cell Buyers and soon after rebranded them as Green Urban Mining to handle their domestic recycling and resale operations.

Green Technology Solutions, Inc. (GTSO), closed Wednesday's trading session at $0.03, even for the day, on 177,073 volume with 12 trades. The average volume for the last 60 days is 201,662 and the stock's 52-week low/high is $0.02/$0.38.


The QualityStocks
Company Corner


OxySure Systems, Inc. (OXYS)

The QualityStocks Daily Newsletter would like to spotlight OxySure® Systems, Inc. (OXYS). Today, OxySure Systems, Inc. closed trading at $0.74, up 5.73%, on 2,800 volume with 4 trades. The stock’s average daily volume over the past 60 days is 8,037, and its 52-week low/high is $0.35/$2.75.

OxySure Systems, Inc. reported today on how their innovative technology for creating medically pure oxygen on the spot from two inert dry powders, as realized most prominently in their FDA-cleared OxySure Model 615, minimizes many of the risks associated with traditional medical oxygen tanks and is easily operated by a lay person, as well as being conveniently located on-site next to automated defibrillators, already having saved thousands of lives. With more than 3 million AED installations around the world, there is a large initial market for the OxySure Model 615 that remains untapped and with reported revenues of $895,413 during the trailing 12-month period, which is 232% higher than its FY 2012 revenues, OXYS is poised for major growth.

OxySure Systems, Inc. (OXYS) is a medical technology company focused on developing, manufacturing, and distributing specialty respiratory and medical solutions. The company has developed a unique platform technology that instantly creates medically pure oxygen from two dry, inert powders, allowing oxygen to be delivered on demand. This cutting-edge technology has already been granted FDA-approved for commercial sale.

The company is targeting multiple enormous end markets with no direct competition. OxySure initially plans to focus on the 102,265 educational campuses, 350,735 manufacturing facilities, 350,000 churches, 12 million recreational vehicles (RVs), 8 million boats and yachts, 950,000 restaurants, and hundreds of thousands of other commercial and municipality facilities in the U.S. Outside the US, OxySure has also already signed significant distribution agreements, including Australia, New Zeeland, the United Kingdom, the Netherlands, Luxembourg, Belgium, Brazil, and South Africa. OxySure’s potential market is at least as large as AEDs and potentially as large as fire extinguishers, which together total at least 500+ million units worldwide.

OxySure’s flagship product, OxySure Model 615, introduces the first new oxygen technology in 50 years. There are no compressed tanks, no dials, no valves, no regulatory maintenance, no hydrostatic testing, no batteries, and no required training, and the technology is both safe and easy-to-use for the layperson. It can be placed virtually anywhere to help save lives by bridging the gap between a medical emergency and the arrival of first responders on the scene.

The company aims to capitalize on market opportunities primarily through partnerships with distributors and OEM customers. Protected by numerous issued patents and patents pending, the company’s products are available over-the-counter without the need for a prescription and has already saved thousands of lives around the globe during various types of medical emergencies. Disclaimer

OxySure Systems, Inc. Company Blog

OxySure Systems, Inc. News:

OxySure Systems: Undervalued, High Growth Potential

OxySure Systems, Inc. Launches OxySure Commercial Finance

OxySure Systems, Inc. to Exhibit at the National Safety Council's (NSC) 2013 Congress & Expo

First Titan Corp. (FTTN)

The QualityStocks Daily Newsletter would like to spotlight First Titan Corp. (FTTN). Today, First Titan Corp. closed trading at $1.71, off by 7.07%, on 387,746 volume with 361 trades. The stock’s average daily volume over the past 60 days is 99,416, and its 52-week low/high is $0.29/$3.70.

First Titan Corp., in a continuing effort to build its asset base, announced today that they have made an offer to a private oil company to partner in the drilling of several new wells in an established shallow oilfield with 23 active wells located over 900 acres in Duval County (South Texas). The active wells previously produced over half a billion barrels of oil and nearly three-quarters of a billion cubic feet of gas.

First Titan Corp. (FTTN), is currently focused on exploring and developing oil and natural gas resources in the southern region of the United Sates, but has a worldwide growth strategy in place. The company continually seeks to partner with energy developers that are pursuing innovative new methods of oil and gas extraction, including the development of new technologies, cleaner methods, and unconventional resources.

First Titan has acquired multiple working interests with established oil exploration companies to deliver new hydrocarbons to an ever-growing market. As the company maintains drilling activities at its acquisition in South Lake Charles, Louisiana, it is looking to continue adding to its asset base that includes five new wells along the Gulf Coast, from West Texas to Alabama.

Global demand for energy is rising fast as the vehicle populations of emerging nations such as China, Brazil, and India continue to soar. U.S. exports of petroleum products have reached 2.6 million barrels a day, which is double the level of three years ago. As demand for global energy resources rises, the U.S. is poised to become an international supplier.

New innovations in drilling and rising global demand have positioned First Titan as a premier early-stage company with strong growth potential. By utilizing cutting-edge technology to extract oil and gas resources, the company is able to recover fossil fuels that were once considered too difficult or too expensive to recover. Disclaimer

First Titan Corp. Company Blog

First Titan Corp. News:

FTTN Targeting Project in Established Oilfield Undergoing Multi-Million Dollar Redevelopment

FTTN Considers the Billions to be Made in Recovery of Flared Gas Reserves

FTTN Exploring Big Money Play in South Texas

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.012, up 71.43%, on 423,750 volume with 18 trades. The stock’s average daily volume over the past 60 days is 247,384, and its 52-week low/high is $0.004/$0.12.

Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.

Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.

Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.

In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings Inc. and The Alternative Initiate New Brand Development Project

Consorteum Holdings Inc. Forms a New, Wholly Owned Subsidiary

Consorteum Holdings, Inc. Appoints Olde Monmouth Stock Transfer Company as New Transfer Agent

Intelimax Media, Inc. (IXMD)

The QualityStocks Daily Newsletter would like to spotlight Intelimax Media, Inc. (IXMD). Today, Intelimax Media, Inc. closed trading at $0.05, up 31.58%, on 41,000 volume with 5 trades. The stock’s average daily volume over the past 60 days is 75,222, and its 52-week low/high is $0.0032/$0.39.

Intelimax Media, Inc. (IXMD) is a digital entertainment company specializing in fantasy sports, social gaming, entertainment, and software solutions. Primarily focused on the daily fantasy sports and social gaming sectors, the company is applying its advanced technologies to fully capitalize on the convergence of key trends in the ever-expanding social gaming space.

The company’s team of experts has identified key opportunities in the rapidly emerging daily fantasy sports and social media sectors. Leveraging its proprietary DraftTeam.com platform, the company is generating multiple revenue streams. Innovative plans for international expansion are underway to maximize exposure and traffic through various online and mobile channels.

It's estimated by the Fantasy Sports Trade Association that over 40 million people play some form of a fantasy sport each year in North America. Participation has grown over 30 percent annually the past four years with 19 percent of all males in the U.S. playing fantasy sports. Fantasy sports are estimated to have a $4–$5 billion annual economic impact across the sports industry.

Intelimax Media offers exciting and entertaining online brands that attract a loyal audience and in turn facilitate lucrative revenues from management fees, product placement, and software sales. Backed by personnel with a proven track record in the finance, growth and development of successful companies, the company is poised for rapid growth in the Internet and entertainment sectors.

Intelimax Media also trades on the Canadian market under the symbol (IMD). Disclaimer

Intelimax Media, Inc. Company Blog

Intelimax Media, Inc. News:

Intelimax Launches New Daily Fantasy Sports Platform on DraftTeam.com

Intelimax Launches New Daily Fantasy Sports Platform on DraftTeam.com

Intelimax - Corporate Update

NanoTech Entertainment, Inc. (NTEK)

The QualityStocks Daily Newsletter would like to spotlight NanoTech Entertainment, Inc. (NTEK). Today, NanoTech Entertainment, Inc. closed trading at $0.169, up 10.10%, on 16,181,167 volume with 1,045 trades. The stock’s average daily volume over the past 60 days is 5,292,993, and its 52-week low/high is $0.0005/$0.157.

NanoTech Entertainment, Inc. (NTEK) is a conglomerate of entertainment companies focused on leveraging technology to deliver state-of-the-art entertainment and communications products. The company’s team is comprised of senior individuals who have been in the entertainment industry for more than 20 years and have a long track record of creating successful products.

Leveraging a diverse portfolio of products and technology, NanoTech is redefining the role of developers and manufacturers in the global market. The company has a unique business model with four technology business units focusing on gaming, media & IPTV, mobile apps, and manufacturing.

NanoTech’s Gaming Labs division operates as a virtual manufacturer, developing its technology and games, and licensing them to third parties for manufacturing and distribution in order to keep its overhead extremely low and operations efficient in the new global manufacturing economy. NanoTech Media develops proprietary technology which it licenses to publishers for use in their products as well as creating and publishing unique content. NanoTech Communications develops and sells proprietary apps and technology in the mobile and consumer space. Clear Memories is the global leader in 3D ice carving and manufacturing technology.

In a recent move to advance into the commercial media space, NanoTech signed a definitive agreement to acquire MagicScreen3D, a leader in the commercial implementation of glassless 3D screen technology. The company is focused on accelerating its corporate growth through additional acquisitions, licensing agreements, partnerships, and executing current business strategies. Leveraging its team’s expertise, NanoTech is well positioned to achieve greater success. Disclaimer

NanoTech Entertainment, Inc. Company Blog

NanoTech Entertainment, Inc. News:

NanoTech Entertainment & LumaForge Partner at SMPTE 2013 Conference and Exhibition

NanoTech Entertainment Retains Sadler Gibb Audit Firm

NanoTech Entertainment Retains DME Law LLP for Hollywood Representation

Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.425, up 2.41%, on 2,024,076 volume with 476 trades. The stock’s average daily volume over the past 60 days is 136,259, and its 52-week low/high is $0.20/$3.50.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global Corp. Announces Engagement of QualityStocks Investor Relations Services

Pan Global, Corp. Discusses Recent Reduction of Issued and Outstanding Shares Agreement With Majority Shareholder, Provides Capitalization Benefit

Pan Global, Corp. Provides Update on Hydro Electric Plant Acquisition

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.40, even for the day, on 8,500 volume with 4 trades. The stock’s average daily volume over the past 60 days is 3,831, and its 52-week low/high is $0.25/$0.95.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve.  According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months.  VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits.  In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations. 

AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data.  To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Provides Update on $36 Million Strategic Financing Agreement

VistaGen Therapeutics Presents CardioSafe 3D and LiverSafe 3D Developments at International Society of Stem Cell Research's 11th Annual Meeting

VistaGen Therapeutics and Duke University Publish Results on Production of Functional 3D Human Heart Tissue

StreamTrack, Inc. (STTK)

The QualityStocks Daily Newsletter would like to spotlight StreamTrack, Inc. (STTK). Today, StreamTrack, Inc. closed trading at $0.08, even with yesterday's close. The stock’s average daily volume over the past 60 days is 1,844, and its 52-week low/high is $0.051/$2.125.

StreamTrack, Inc. (STTK), a digital media and technology services company, provides audio and video streaming and advertising services through its RadioLoyalty™ Platform to a global group of internet and terrestrial radio stations, internet radio guides, and other broadcast content providers. The company's platform powers a web-based and mobile player that manages streaming audio and video content, social media engagement, and ad serving.

StreamTrack offers its platform directly to broadcasters and integrates or white labels its technologies with web-based internet radio guides and other web-based content providers. With StreamTrack technology, broadcasters and publishers are able to maximize their revenue while decreasing expenses, while advertisers are provided with a cost-effective means to reach their target audience from one source at scale.

WatchThis™, StreamTrack's patent-pending technology designed to provide web, mobile, and IP television streaming services that are e-commerce enabled within streamed content, could revolutionize the entertainment industry by combining original network content with interactive product placement. Recognizing the convergence of traditional televised advertisement and internet technology, StreamTrack is advancing its WatchThis™ technology to lead the revolution taking place.

StreamTrack is dedicated to continually creating and managing innovative technology products to provide broadcasters and content owners the most advanced solutions available in the marketplace. Fully committed to also increasing and protecting shareholder value, the management team carefully executes operational, development, and marketing programs with the primary aim of maximizing the company's growth potential and profitability. Disclaimer

StreamTrack, Inc. Company Blog

StreamTrack, Inc. News:

StreamTrack Announces Cancellation of Potential $2.5 Million Royalty Liability

StreamTrack's RadioLoyalty Signs TargetSpot

StreamTrack's RadioLoyalty Platform Adds Over 3,000 Stations


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



The Green Baron




Wall Street Profit Search

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251